Synbiotic formula shows promise in reducing long COVID symptoms

Study finds that the synbiotic preparation SIM01 significantly reduces post-acute COVID-19 syndrome symptoms in patients, including fatigue, memory issues, and gastrointestinal distress, indicating its potential as a treatment for long COVID.

Opinion | What You Don’t Know About Leprosy

Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan. In this video, Claire Panosian Dunavan, MD, professor

August 22, 2023

FDA grants priority review for Neurocrine’s crinecerfont NDAs

The asset is intended to treat congenital adrenal hyperplasia in paediatric and adult patients. Credit: YURIMA / Shutterstock. The US Food and Drug Administration (FDA)

July 2, 2024

CDC advisory panel says people 65 and older should get a Covid spring booster shot

An expert panel advising the Centers for Disease Control and Prevention on vaccines on Wednesday recommended that people 65 and older should get an additional

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.